Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Two cases of somatic STK11 mosaicism in Danish patients with Peutz-Jeghers syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Risk of multiple colorectal cancer development depends on age and subgroup in individuals with hereditary predisposition

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Parenthood among men diagnosed with cancer in childhood and early adulthood: trends over time in a Danish national cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Increasing use of genomic sequencing enables standardized screening of all childhood cancer predisposition syndromes (CPS) in children with cancer. Gene panels currently used often include adult-onset CPS genes and genes without substantial evidence linking them to cancer predisposition. We have developed criteria to select genes relevant for childhood-onset CPS and assembled a gene panel for use in children with cancer. We applied our criteria to 381 candidate genes, which were selected through two in-house panels (n = 338), a literature search (n = 39), and by assessing two Genomics England's PanelApp panels (n = 4). We developed evaluation criteria that determined a gene's eligibility for inclusion on a childhood-onset CPS gene panel. These criteria assessed (1) relevance in childhood cancer by a minimum of five childhood cancer patients reported carrying a pathogenic variant in the gene and (2) evidence supporting a causal relation between variants in this gene and cancer development. 138 genes fulfilled the criteria. In this study we have developed criteria to compile a childhood cancer predisposition gene panel which might ultimately be used in a clinical setting, regardless of the specific type of childhood cancer. This panel will be evaluated in a prospective study. The panel is available on (pediatric-cancer-predisposition-genepanel.nl) and will be regularly updated.

OriginalsprogEngelsk
TidsskriftFamilial Cancer
ISSN1389-9600
DOI
StatusE-pub ahead of print - 1 jun. 2021

ID: 66476896